Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 18Non-Muscle Invasive Bladder Neoplasms 12Carcinoma, Transitional Cell 11Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Anus Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma 3Urologic Neoplasms 2Urologic Diseases 2Urogenital Neoplasms 2Urinary Bladder Diseases 2Stomach Neoplasms 2Neoplasms by Site 2Colonic Neoplasms 2Anal Canal Carcinoma 2Uterine Cervical Neoplasms 1Urogenital Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mycobacterium Infections 1

Interventions

Paclitaxel 2Fluorouracil 2Cisplatin 2zalutumumab 1sintilimab 1pembrolizumab 1Radiotherapy 1Neoadjuvant Therapy 1Mitomycins 1Mitomycin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Squamous Cell × Mitomycin × Clear all
NCT02526953 2021-02-09

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Blokhin's Russian Cancer Research Center

Phase 3 Unknown
314 enrolled
Gastrointestinal

Anus Diseases, Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡